相似文献
1
CRISPR-based adaptive immune systems.
Curr Opin Microbiol. 2011 Jun;14(3):321-7. doi: 10.1016/j.mib.2011.03.005. Epub 2011 Apr 29.
2
Viral diversity threshold for adaptive immunity in prokaryotes.
mBio. 2012 Dec 4;3(6):e00456-12. doi: 10.1128/mBio.00456-12.
3
In defense of phage: viral suppressors of CRISPR-mediated adaptive immunity in bacteria.
RNA Biol. 2013 May;10(5):886-90. doi: 10.4161/rna.23591.
4
CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation.
Annu Rev Genet. 2011;45:273-97. doi: 10.1146/annurev-genet-110410-132430.
5
RNA-guided genetic silencing systems in bacteria and archaea.
Nature. 2012 Feb 15;482(7385):331-8. doi: 10.1038/nature10886.
6
CRISPR/Cas, the immune system of bacteria and archaea.
Science. 2010 Jan 8;327(5962):167-70. doi: 10.1126/science.1179555.
7
CRISPR-Cas systems and RNA-guided interference.
Wiley Interdiscip Rev RNA. 2013 May-Jun;4(3):267-78. doi: 10.1002/wrna.1159. Epub 2013 Mar 20.
8
The CRISPR system: small RNA-guided defense in bacteria and archaea.
Mol Cell. 2010 Jan 15;37(1):7-19. doi: 10.1016/j.molcel.2009.12.033.
9
CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea.
Nat Rev Genet. 2010 Mar;11(3):181-90. doi: 10.1038/nrg2749.
10
CRISPR-mediated adaptive immune systems in bacteria and archaea.
Annu Rev Biochem. 2013;82:237-66. doi: 10.1146/annurev-biochem-072911-172315. Epub 2013 Mar 11.
引用本文的文献
1
CRISPR/Cas-Based Nanobiosensor Using Plasmonic Nanomaterials to Detect Disease Biomarkers.
Biochip J. 2025;19(2):167-181. doi: 10.1007/s13206-024-00183-x. Epub 2025 Feb 13.
2
Application of CRISPR/Cas gene editing for infectious disease control in poultry.
Open Life Sci. 2025 May 20;20(1):20251095. doi: 10.1515/biol-2025-1095. eCollection 2025.
3
Advancing cancer gene therapy: the emerging role of nanoparticle delivery systems.
J Nanobiotechnology. 2025 May 20;23(1):362. doi: 10.1186/s12951-025-03433-8.
4
Novel application of ribonucleoprotein-mediated CRISPR-Cas9 gene editing in plant pathogenic oomycete species.
Microbiol Spectr. 2025 Apr;13(4):e0301224. doi: 10.1128/spectrum.03012-24. Epub 2025 Feb 27.
5
Synthetic biology meets Aspergillus: engineering strategies for next-generation organic acid production.
World J Microbiol Biotechnol. 2025 Jan 13;41(2):36. doi: 10.1007/s11274-024-04246-x.
6
SspA is a transcriptional regulator of CRISPR adaptation in E. coli.
Nucleic Acids Res. 2025 Feb 8;53(4). doi: 10.1093/nar/gkae1244.
7
Digital CRISPR-Powered Biosensor Concept without Target Amplification Using Single-Impact Electrochemistry.
ACS Sens. 2024 Nov 22;9(11):6197-6206. doi: 10.1021/acssensors.4c02060. Epub 2024 Oct 22.
8
Innate and germline immune memory: specificity and heritability of the ancient immune mechanisms for adaptation and survival.
Front Immunol. 2024 Jun 6;15:1386578. doi: 10.3389/fimmu.2024.1386578. eCollection 2024.
9
Characteristics and immune functions of the endogenous CRISPR-Cas systems in myxobacteria.
mSystems. 2024 Jun 18;9(6):e0121023. doi: 10.1128/msystems.01210-23. Epub 2024 May 15.
10
Mechanisms used for cDNA synthesis and site-specific integration of RNA into DNA genomes by a reverse transcriptase-Cas1 fusion protein.
Sci Adv. 2024 Apr 12;10(15):eadk8791. doi: 10.1126/sciadv.adk8791.
本文引用的文献
1
Evolution and classification of the CRISPR-Cas systems.
Nat Rev Microbiol. 2011 Jun;9(6):467-77. doi: 10.1038/nrmicro2577. Epub 2011 May 9.
2
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.
Nature. 2011 Mar 31;471(7340):602-7. doi: 10.1038/nature09886.
3
In vivo activity of CRISPR-mediated virus defence in a hyperthermophilic archaeon.
Mol Microbiol. 2011 Apr;80(2):481-91. doi: 10.1111/j.1365-2958.2011.07586.x. Epub 2011 Mar 8.
4
Interaction of the Cas6 riboendonuclease with CRISPR RNAs: recognition and cleavage.
Structure. 2011 Feb 9;19(2):257-64. doi: 10.1016/j.str.2010.11.014.
5
CRISPR-based immune systems of the Sulfolobales: complexity and diversity.
Biochem Soc Trans. 2011 Jan;39(1):51-7. doi: 10.1042/BST0390051.
6
A dual function of the CRISPR-Cas system in bacterial antivirus immunity and DNA repair.
Mol Microbiol. 2011 Jan;79(2):484-502. doi: 10.1111/j.1365-2958.2010.07465.x. Epub 2010 Dec 7.
7
Dynamic properties of the Sulfolobus CRISPR/Cas and CRISPR/Cmr systems when challenged with vector-borne viral and plasmid genes and protospacers.
Mol Microbiol. 2011 Jan;79(1):35-49. doi: 10.1111/j.1365-2958.2010.07452.x. Epub 2010 Nov 18.
8
Analysis of streptococcal CRISPRs from human saliva reveals substantial sequence diversity within and between subjects over time.
Genome Res. 2011 Jan;21(1):126-36. doi: 10.1101/gr.111732.110. Epub 2010 Dec 13.
9
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA.
Nature. 2010 Nov 4;468(7320):67-71. doi: 10.1038/nature09523.
10
CRISPR associated diversity within a population of Sulfolobus islandicus.
PLoS One. 2010 Sep 28;5(9):e12988. doi: 10.1371/journal.pone.0012988.
Zotero 插件